Explore
Premium
Sign Up
Log In
CRT 2017 : FDA VALVE - Tricuspid Valve Therapies: The New Kid on the Block
Conference
Add this Moment to your Passport
Learn from this moment and keep it forever.
Add To Passport
$8.99
This moment is included in Simple Premium - Get started for free.
FREE
with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments.
$30.00 per month. Cancel anytime.
Overview
FDA VALVE - Tricuspid Valve Therapies: The New Kid on the Block
Featuring
Azeem Latib
Steven Bolling
Azeem Latib
Bernard Vasseur
Add this Moment to your Passport
Learn from this moment and keep it forever.
Add To Passport
$8.99
This moment is included in Simple Premium - Get started for free.
FREE
with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments.
$30.00 per month. Cancel anytime.
Moment Components
Tricuspid Regurgitation – Etiology and Medical Therapy - Azeem Latib
Role of Surgical Therapy in Tricuspid Regurgitation - Steven Bolling
Lessons Learned from Early FIH/EFS Trials: Tricuspid Valve Repair Technologies - Azeem Latib
The Known Knowns and the Known Unknowns - FDA Perspective - Bernard Vasseur
Target Audience
Learning Objectives
Related Moments
CRT 2017: ATHEROSCLEROSIS, PHYSIOLOGY AND IMAGING - New Insights into the Pathophysiology of the Atherosclerotic Plaque
Conference
Concurrent Coronary Artery and Valvular Heart Disease - Hybrid Treatment Strategies in 2013
Journal
Article on Concurrent Coronary Artery and Valvular Heart Disease - Hybrid Treatment Strategies in 2013
CRT 2016 Atherosclerosis & Research - Vulnerable Plaque Clinical Trials Update
Conference
A session discussing the updates in Vulnerable Plaque Clinical Trials
Loading Simple Education